Sunmax Biotechnology Gestion

Gestion contrôle des critères 0/4

Nous ne disposons actuellement pas d’informations suffisantes sur le PDG.

Informations clés

Ming Yi Lin

Directeur général

n/a

Rémunération totale

Pourcentage du salaire du PDG	n/a
Durée du mandat du directeur général	no data
Propriété du PDG	n/a
Durée moyenne d'occupation des postes de direction	pas de données
Durée moyenne du mandat des membres du conseil d'administration	pas de données

Mises à jour récentes de la gestion

Recent updates

Investors Who Bought Sunmax Biotechnology (GTSM:4728) Shares Three Years Ago Are Now Up 166%

Feb 28

Is Sunmax Biotechnology Co., Ltd. (GTSM:4728) The Right Choice For A Smart Dividend Investor?

Feb 02

Sunmax Biotechnology Co., Ltd.'s (GTSM:4728) Stock Is Going Strong: Is the Market Following Fundamentals?

Dec 20

Is Sunmax Biotechnology's (GTSM:4728) Share Price Gain Of 152% Well Earned?

Nov 24

PDG

Ming Yi Lin

no data

Titularisation

Mr. Ming Yi Lin serves as Manager of Sunmax Biotechnology Co., Ltd.

Sunmax Biotechnology Gestion

Gestion contrôle des critères 0/4

Informations clés

Mises à jour récentes de la gestion

Sunmax Biotechnology Co., Ltd., Annual General Meeting, Jun 28, 2024

Sunmax Biotechnology Co., Ltd., Annual General Meeting, Jun 20, 2022

Recent updates

Third quarter 2024 earnings released: EPS: NT$3.15 (vs NT$3.39 in 3Q 2023)

Second quarter 2024 earnings released: EPS: NT$3.35 (vs NT$2.65 in 2Q 2023)

Upcoming dividend of NT$11.00 per share

Now 21% overvalued after recent price rise

New minor risk - Share price stability

Now 23% overvalued after recent price rise

Investor sentiment improves as stock rises 19%

First quarter 2024 earnings released: EPS: NT$3.24 (vs NT$2.35 in 1Q 2023)

Sunmax Biotechnology Co., Ltd., Annual General Meeting, Jun 28, 2024

Full year 2023 earnings released: EPS: NT$11.49 (vs NT$9.80 in FY 2022)

New minor risk - Share price stability

Third quarter 2023 earnings released: EPS: NT$3.39 (vs NT$2.52 in 3Q 2022)

Second quarter 2023 earnings released: EPS: NT$2.65 (vs NT$2.55 in 2Q 2022)

Upcoming dividend of NT$9.50 per share at 4.1% yield

Investor sentiment deteriorates as stock falls 16%

Investor sentiment improves as stock rises 23%

Investor sentiment deteriorated over the past week

Third quarter 2022 earnings released: EPS: NT$2.52 (vs NT$0.76 in 3Q 2021)

Second quarter 2022 earnings released: EPS: NT$2.55 (vs NT$0.82 in 2Q 2021)

Investor sentiment improved over the past week

Upcoming dividend of NT$4.40 per share

Sunmax Biotechnology Co., Ltd., Annual General Meeting, Jun 20, 2022

Full year 2021 earnings released: EPS: NT$4.51 (vs NT$4.37 in FY 2020)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS NT$0.76 (vs NT$0.35 in 3Q 2020)

Upcoming dividend of NT$2.00 per share

Second quarter 2021 earnings released: EPS NT$0.81 (vs NT$1.12 in 2Q 2020)

First quarter 2021 earnings released: EPS NT$1.16 (vs NT$1.03 in 1Q 2020)

Full year 2020 earnings released: EPS NT$4.37 (vs NT$1.84 in FY 2019)

Investors Who Bought Sunmax Biotechnology (GTSM:4728) Shares Three Years Ago Are Now Up 166%

Is Sunmax Biotechnology Co., Ltd. (GTSM:4728) The Right Choice For A Smart Dividend Investor?

New 90-day high: NT$78.90

Sunmax Biotechnology Co., Ltd.'s (GTSM:4728) Stock Is Going Strong: Is the Market Following Fundamentals?

New 90-day high: NT$72.70

Is Sunmax Biotechnology's (GTSM:4728) Share Price Gain Of 152% Well Earned?

Third quarter 2020 earnings released: EPS NT$0.35

New 90-day low - NT$67.60

Earnings released

New 90-day low - NT$73.30

PDG

Titularisation